Evidence map›Paper›PMID 29042434›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Trafficking of Kv2.1 Channels to the Axon Initial Segment by a Novel Nonconventional Secretory Pathway.

Camilla Stampe Jensen, Shoji Watanabe, Jeroen Ingrid Stas, Jessica Klaphaak, Ayaka Yamane, Nicole Schmitt, Søren-Peter Olesen, James S Trimmer, Hanne Borger Rasmussen, Hiroaki Misonou

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Cytoskeletal scaffolding of NaCurrent opinion in cell biology · 2025
    Review
  5. Article
  6. Kv2.1 negatively regulates Reissner fiber development.Frontiers in cell and developmental biology · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. A novel autism-associatedFrontiers in cellular neuroscience · 2024
    Article
  11. Article
  12. Article
  13. Increased KCells · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 5 countries.

Camilla Stampe JensenDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.ORCID 0000-0001-6546-8630
Shoji WatanabeLaboratory of Ion Channel Pathophysiology, Graduate School of Brain Science, Doshisha University, Kyoto 610-0394, Japan.
Jeroen Ingrid StasDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
Jessica KlaphaakDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
Ayaka YamaneLaboratory of Ion Channel Pathophysiology, Graduate School of Brain Science, Doshisha University, Kyoto 610-0394, Japan.
Nicole SchmittDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.ORCID 0000-0001-9482-9749
Søren-Peter OlesenDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
James S TrimmerDepartments of Neurobiology, Physiology and Behavior, and.ORCID 0000-0002-6117-3912
Hanne Borger RasmussenDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.ORCID 0000-0002-2218-5646
Hiroaki MisonouLaboratory of Ion Channel Pathophysiology, Graduate School of Brain Science, Doshisha University, Kyoto 610-0394, Japan, h_misonou@mac.com.ORCID 0000-0001-5892-1804
University of Copenhagen · DKDoshisha University · JPInstitute of Neurobiology · BG

Funding

Determinants of Dendritic Potassium Channel LocalizationR01NS042225 · NINDS · UNIVERSITY OF CALIFORNIA DAVIS · PI TRIMMER, JAMES S · 2001 to 2014
$6.3M
NINDS NIH HHS R01 NS042225
6 · The paper itself

Abstract

Kv2.1 is a major delayed-rectifier voltage-gated potassium channel widely expressed in neurons of the CNS. Kv2.1 localizes in high-density cell-surface clusters in the soma and proximal dendrites as well as in the axon initial segment (AIS). Given the crucial roles of both of these compartments in integrating signal input and then generating output, this localization of Kv2.1 is ideal for regulating the overall excitability of neurons. Here we used fluorescence recovery after photobleaching imaging, mutagenesis, and pharmacological interventions to investigate the molecular mechanisms that control the localization of Kv2.1 in these two different membrane compartments in cultured rat hippocampal neurons of mixed sex. Our data uncover a unique ability of Kv2.1 channels to use two molecularly distinct trafficking pathways to accomplish this. Somatodendritic Kv2.1 channels are targeted by the conventional secretory pathway, whereas axonal Kv2.1 channels are targeted by a nonconventional trafficking pathway independent of the Golgi apparatus. We further identified a new AIS trafficking motif in the C-terminus of Kv2.1, and show that putative phosphorylation sites in this region are critical for the restricted and clustered localization in the AIS. These results indicate that neurons can regulate the expression and clustering of Kv2.1 in different membrane domains independently by using two distinct localization mechanisms, which would allow neurons to precisely control local membrane excitability.

Indexed as

AnimalsAxon Initial SegmentCell MembraneCells, CulturedFemaleHEK293 CellsHippocampusHumansMaleNeuronsProtein TransportRatsSecretory PathwayShab Potassium ChannelsKcnb1 protein, ratShab Potassium Channelsexcitabilityphosphorylationpotassium channelsortingtargeting

Identifiers

PMID29042434
PMCPMC6705746
OpenAlexW2765919951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.